{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:41Z","timestamp":1791247961569,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Projects Fund for Scientific Research of Higher Education Institutions in Anhui Province","award":["NO\uff1a2023AH053356"],"award-info":[{"award-number":["NO\uff1a2023AH053356"]}]},{"name":"the Key Project of the Anhui Provincial Sci-Tech Innovation Breakthrough Plan","award":["No. 202423k09020009"],"award-info":[{"award-number":["No. 202423k09020009"]}]},{"name":"the Key Project of the Scientific Research Program of Anhui Provincial Health Commission","award":["No. AHWJ2023A10028"],"award-info":[{"award-number":["No. AHWJ2023A10028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05661-4","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:51:35Z","timestamp":1784706695000},"page":"4197-4214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BRSK2 accumulation mediated by TRIM28 accelerates hepatocellular carcinoma progression via activating the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1007","volume":"481","author":[{"given":"Shengjin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"5","key":"5661_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, Ngeow J (2023) Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 164(5):766\u2013782","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"5661_CR2","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","volume":"31","author":"SY Hwang","year":"2025","unstructured":"Hwang SY, Danpanichkul P, Agopian V, Mehta N, Parikh ND, Abou-Alfa GK, Singal AG, Yang JD (2025) Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clin Mol Hepatol 31(Suppl):S228\u2013s254","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"5661_CR3","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3390\/ijms26051936","volume":"26","author":"M Bloom","year":"2025","unstructured":"Bloom M, Podder S, Dang H, Lin D (2025) Advances in Immunotherapy in Hepatocellular Carcinoma. Int J Mol Sci 26(5):1936","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5661_CR4","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/gutjnl-2025-334928","volume":"74","author":"M Pinter","year":"2025","unstructured":"Pinter M, Fulgenzi CAM, Pinato DJ, Scheiner B (2025) Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction. Gut 74(7):1178\u20131188","journal-title":"Gut"},{"issue":"1","key":"5661_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target therapy 7(1):286","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"5661_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-024-01545-6","volume":"17","author":"S Zhou","year":"2024","unstructured":"Zhou S, Liu J, Wan A, Zhang Y, Qi X (2024) Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis. J Hematol Oncol 17(1):22","journal-title":"J Hematol Oncol"},{"issue":"2","key":"5661_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115665232399193250529074831","volume":"26","author":"G Wang","year":"2026","unstructured":"Wang G, Yan S, Zhang L, Lin L, Liu R, Han Y, Zhao Y (2026) Machine Learning-Driven PCDI Classifier for Invasive PitNETs. Curr Gene Ther 26(2):1\u201316","journal-title":"Curr Gene Ther"},{"issue":"18","key":"5661_CR8","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"SK Hsu","year":"2021","unstructured":"Hsu SK, Li CY, Lin IL, Syue WJ, Chen YF, Cheng KC, Teng YN, Lin YH, Yen CH, Chiu CC (2021) Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics 11(18):8813\u20138835","journal-title":"Theranostics"},{"issue":"4","key":"5661_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajhg.2019.02.002","volume":"104","author":"SM Hiatt","year":"2019","unstructured":"Hiatt SM, Thompson ML, Prokop JW, Lawlor JMJ, Gray DE, Bebin EM, Rinne T, Kempers M, Pfundt R, van Bon BW et al (2019) Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder. Am J Hum Genet 104(4):701\u2013708","journal-title":"Am J Hum Genet"},{"issue":"1","key":"5661_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12916-025-03848-y","volume":"23","author":"Z Chen","year":"2025","unstructured":"Chen Z, Tang M, Wang N, Liu J, Tan X, Ma H, Luo J, Xie K (2025) Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis. BMC Med 23(1):22","journal-title":"BMC Med"},{"issue":"1","key":"5661_CR11","doi-asserted-by":"publisher","first-page":"40651","DOI":"10.1038\/s41598-025-24354-4","volume":"15","author":"A Maiti","year":"2025","unstructured":"Maiti A, Axtman AD, Wu R, Redman LJB, Takabe K, Stablewski AB, Yan L, Ciesielski MJ, Zhang J, Evans SS et al (2025) BRSK2 plays a role in autophagy and cancer cell growth and survival under nutrient deprivation stress via the PIK3C3 pathway. Sci Rep 15(1):40651","journal-title":"Sci Rep"},{"issue":"27","key":"5661_CR12","doi-asserted-by":"publisher","first-page":"44669","DOI":"10.18632\/oncotarget.17965","volume":"8","author":"H Saiyin","year":"2017","unstructured":"Saiyin H, Na N, Han X, Fang Y, Wu Y, Lou W, Yang X (2017) BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity. Oncotarget 8(27):44669\u201344681","journal-title":"Oncotarget"},{"issue":"2","key":"5661_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15548627.2024.2395727","volume":"21","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Chen S, Jun S, Xu X, Hong Y, Yang X, Zou L, Song YQ, Chen Y, Tu J (2025) MLKL-USP7-UBA52 signaling is indispensable for autophagy in brain through maintaining ubiquitin homeostasis. Autophagy 21(2):424\u2013446","journal-title":"Autophagy"},{"issue":"2","key":"5661_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbrc.2019.08.069","volume":"518","author":"Y Tang","year":"2019","unstructured":"Tang Y, Yu W (2019) SIRT1 and p300\/CBP regulate the reversible acetylation of serine-threonine kinase NDR2. Biochem Biophys Res Commun 518(2):396\u2013401","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"5661_CR15","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.molcel.2025.02.024","volume":"85","author":"X He","year":"2025","unstructured":"He X, Chen D, Liu G, Wu Q, Zhao H, Guo D, Jiang X, Li M, Meng Y, Yin Y et al (2025) PI3K\u03b2 functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth. Mol Cell 85(7):1411\u20131425e1418","journal-title":"Mol Cell"},{"issue":"1","key":"5661_CR16","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/s41467-023-39600-4","volume":"14","author":"D Tan","year":"2023","unstructured":"Tan D, Lu M, Cai Y, Qi W, Wu F, Bao H, Qv M, He Q, Xu Y, Wang X et al (2023) SUMOylation of Rho-associated protein kinase 2 induces goblet cell metaplasia in allergic airways. Nat Commun 14(1):3887","journal-title":"Nat Commun"},{"issue":"4","key":"5661_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbrc.2012.05.045","volume":"422","author":"J Zhou","year":"2012","unstructured":"Zhou J, Wan B, Li R, Gu X, Zhong Z, Wang Y, Yu L (2012) Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway. Biochem Biophys Res Commun 422(4):647\u2013652","journal-title":"Biochem Biophys Res Commun"},{"issue":"7\u20138","key":"5661_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10495-021-01682-0","volume":"26","author":"X Dai","year":"2021","unstructured":"Dai X, Wang D, Zhang J (2021) Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis: Int J Program cell death 26(7\u20138):385\u2013414","journal-title":"Apoptosis: Int J Program cell death"},{"issue":"10","key":"5661_CR19","doi-asserted-by":"publisher","first-page":"e010008","DOI":"10.1136\/jitc-2024-010008","volume":"12","author":"L Zhang","year":"2024","unstructured":"Zhang L, Cui Y, Zhou G, Zhang Z, Zhang P (2024) Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma. J Immunother Cancer 12(10):e010008","journal-title":"J Immunother Cancer"},{"issue":"2","key":"5661_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D (2021) Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 28(2):591\u2013605","journal-title":"Cell Death Differ"},{"issue":"12","key":"5661_CR21","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41388-022-02199-9","volume":"41","author":"BV Howley","year":"2022","unstructured":"Howley BV, Mohanty B, Dalton A, Grelet S, Karam J, Dincman T, Howe PH (2022) The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression. Oncogene 41(12):1679\u20131690","journal-title":"Oncogene"},{"issue":"3","key":"5661_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5582\/bst.2022.01245","volume":"16","author":"H Maki","year":"2022","unstructured":"Maki H, Hasegawa K (2022) Advances in the surgical treatment of liver cancer. Biosci Trends 16(3):178\u2013188","journal-title":"Biosci Trends"},{"key":"5661_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.actbio.2021.05.031","volume":"130","author":"L Liu","year":"2021","unstructured":"Liu L, Liang X, Xu X, Zhang X, Wen J, Chen K, Su X, Teng Z, Lu G, Xu J (2021) Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer. Acta Biomater 130:374\u2013384","journal-title":"Acta Biomater"},{"issue":"1","key":"5661_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00423-025-03766-w","volume":"410","author":"CY Hsieh","year":"2025","unstructured":"Hsieh CY, Yong CC, Liu YW, Li WF, Wang CC, Yen YH, Lin CY (2025) Predictors of long-term survival outcomes of patients with hepatocellular carcinoma without recurrence at five years after liver resection. Langenbeck\u2019s archives Surg 410(1):182","journal-title":"Langenbeck\u2019s archives Surg"},{"issue":"1","key":"5661_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1568009615666150916092903","volume":"16","author":"EI Marks","year":"2016","unstructured":"Marks EI, Yee NS (2016) Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma. Curr Cancer Drug Targets 16(1):53\u201370","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"5661_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41420-024-02116-x","volume":"10","author":"X Wu","year":"2024","unstructured":"Wu X, Cao J, Wan X, Du S (2024) Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects. Cell death discovery 10(1):356","journal-title":"Cell death discovery"},{"issue":"1","key":"5661_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX (2024) Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol 17(1):25","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5661_CR28","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41467-025-56898-4","volume":"16","author":"S Naghdi","year":"2025","unstructured":"Naghdi S, Mishra P, Roy SS, Weaver D, Walter L, Davies E, Antony AN, Lin X, Moehren G, Feitelson MA et al (2025) VDAC2 and Bak scarcity in liver mitochondria enables targeting hepatocarcinoma while sparing hepatocytes. Nat Commun 16(1):2416","journal-title":"Nat Commun"},{"issue":"1","key":"5661_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, Song Y, Zhou Y, Zhao X, Zhang Y et al (2023) SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ 30(1):137\u2013151","journal-title":"Cell Death Differ"},{"issue":"1","key":"5661_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12672-024-01167-x","volume":"15","author":"T Li","year":"2024","unstructured":"Li T, Zhang L (2024) Autophagy-related biomarkers in hepatocellular carcinoma and their relationship with immune infiltration. Discover Oncol 15(1):299","journal-title":"Discover Oncol"},{"issue":"2","key":"5661_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, Dai HQ, Huang XW, Feng J, Deng JH, Wang ZX, Yang XM, Liu YJ, Wu Y, Chen PH et al (2021) Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin 42(2):301\u2013310","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"5661_CR32","doi-asserted-by":"publisher","first-page":"e14351","DOI":"10.15252\/emmm.202114351","volume":"13","author":"R Gao","year":"2021","unstructured":"Gao R, Kalathur RKR, Coto-Llerena M, Ercan C, Buechel D, Shuang S, Piscuoglio S, Dill MT, Camargo FD, Christofori G et al (2021) YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol Med 13(12):e14351","journal-title":"EMBO Mol Med"},{"issue":"1\u20132","key":"5661_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jneuroim.2005.08.011","volume":"170","author":"L Sabater","year":"2005","unstructured":"Sabater L, G\u00f3mez-Choco M, Saiz A, Graus F (2005) BR serine\/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis. J Neuroimmunol 170(1\u20132):186\u2013190","journal-title":"J Neuroimmunol"},{"issue":"1","key":"5661_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1074\/jbc.M806152200","volume":"284","author":"S Fogarty","year":"2009","unstructured":"Fogarty S, Hardie DG (2009) C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest. J Biol Chem 284(1):77\u201384","journal-title":"J Biol Chem"},{"issue":"36","key":"5661_CR35","doi-asserted-by":"publisher","first-page":"30368","DOI":"10.1074\/jbc.M112.375618","volume":"287","author":"XY Chen","year":"2012","unstructured":"Chen XY, Gu XT, Saiyin H, Wan B, Zhang YJ, Li J, Wang YL, Gao R, Wang YF, Dong WP et al (2012) Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively regulates glucose-stimulated insulin secretion in pancreatic \u03b2-cells. J Biol Chem 287(36):30368\u201330375","journal-title":"J Biol Chem"},{"key":"5661_CR36","doi-asserted-by":"publisher","first-page":"216842","DOI":"10.1016\/j.canlet.2024.216842","volume":"590","author":"K Li","year":"2024","unstructured":"Li K, Lin H, Liu A, Qiu C, Rao Z, Wang Z, Chen S, She X, Zhu S, Li P et al (2024) SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG. Cancer Lett 590:216842","journal-title":"Cancer Lett"},{"issue":"3","key":"5661_CR37","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms24032652","volume":"24","author":"LY Tian","year":"2023","unstructured":"Tian LY, Smit DJ, J\u00fccker M (2023) The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int J Mol Sci 24(3):2652","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5661_CR38","doi-asserted-by":"publisher","first-page":"111194","DOI":"10.1016\/j.celrep.2022.111194","volume":"40","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhang H, Meng J, Guo F, Ren D, Wu H, Jin X (2022) S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K\/AKT pathway. Cell Rep 40(7):111194","journal-title":"Cell Rep"},{"issue":"1","key":"5661_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, Xin H (2022) TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Experimental Hematol Oncol 11(1):75","journal-title":"Experimental Hematol Oncol"},{"issue":"1","key":"5661_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","volume":"8","author":"X Ma","year":"2023","unstructured":"Ma X, Jia S, Wang G, Liang M, Guo T, Du H, Li S, Li X, Huangfu L, Guo J et al (2023) TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduct Target therapy 8(1):246","journal-title":"Signal Transduct Target therapy"},{"issue":"14","key":"5661_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.scib.2019.05.024","volume":"64","author":"J Cui","year":"2019","unstructured":"Cui J, Hu J, Ye Z, Fan Y, Li Y, Wang G, Wang L, Wang Z (2019) TRIM28 protects CARM1 from proteasome-mediated degradation to prevent colorectal cancer metastasis. Sci Bull 64(14):986\u2013997","journal-title":"Sci Bull"},{"issue":"1","key":"5661_CR42","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1038\/s41467-018-07475-5","volume":"9","author":"KW Fong","year":"2018","unstructured":"Fong KW, Zhao JC, Song B, Zheng B, Yu J (2018) TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression. Nat Commun 9(1):5007","journal-title":"Nat Commun"},{"issue":"1","key":"5661_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41467-021-27944-8","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Lu H, Chen C, Lyu Y, Cole RN, Semenza GL (2022) HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia. Nat Commun 13(1):316","journal-title":"Nat Commun"},{"issue":"4","key":"5661_CR44","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0195-5616(85)50033-9","volume":"15","author":"RE Matus","year":"1985","unstructured":"Matus RE, Leifer CE (1985) Immunoglobulin-producing tumors. Veterinary Clin North Am Small Anim Pract 15(4):741\u2013753","journal-title":"Veterinary Clin North Am Small Anim Pract"},{"issue":"5","key":"5661_CR45","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.jbc.2023.104621","volume":"299","author":"T Song","year":"2023","unstructured":"Song T, Lv S, Ma X, Zhao X, Fan L, Zou Q, Li N, Yan Y, Zhang W, Sun L (2023) TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3\/KDM6A-regulated autophagy. J Biol Chem 299(5):104621","journal-title":"J Biol Chem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05661-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:05:26Z","timestamp":1791245126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05661-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5661"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05661-4","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}